Posted on 10/02/2021 9:44:43 PM PDT by SeekAndFind
Shares of Merck & Co surged on positive clinical trial results of its experimental antiviral COVID-19 pill while high-flying stocks of vaccine companies and makers of other coronavirus therapies were bruised.
Merck shares jumped as much as 12.3 percent and hit their highest level since February 2020 after data showed the company’s pill molnupiravir could halve the chances of dying or being hospitalized for those most at risk of contracting severe COVID-19.
Meanwhile, shares of vaccine makers such as Moderna Inc, Pfizer Inc, and partner BioNTech SE crumbled. Moderna shares fell 13 percent in midday trading, while Pfizer, which is developing a COVID-19 pill of its own, fell 1.3 percent. U.S. shares of BioNTech dropped 11 percent.
Profit-taking was a likely factor behind the selloffs, some analysts said. Others believe the promise of an oral drug that can be taken at home could change the public perception of risks associated with COVID-19.
“We see modest perceived headwind to vaccine stocks such as MRNA (Moderna) if the market thinks people will be less afraid of COVID-19 and less inclined to get vaccines, if there is a simple pill that can treat COVID-19,” Jefferies analyst Michael Yee wrote in a client note.
Despite the recent dip, Moderna shares are up over 395 percent over the past year and 1,734 percent over the past five years. Pfizer stock is up nearly 25 percent over the past year and around 35 percent over the past five years.
Merck said Friday that results from a clinical trial into its COVID-19 pill cut the risk of hospitalization or death in half for adults who were deemed at risk but not hospitalized.
Based on the findings, Merck plans to apply to the Food and Drug Administration (FDA) soon for emergency use authorization for its drug,
(Excerpt) Read more at theepochtimes.com ...
yeah
won’t take their crap
I am invested in Pharma but its a mix so I guess the Merck side will outweigh the others.
Any bets that the damn thing is ivermectin + HCQ with about a 10,000% markup?
Don’t know about ingredients, but markup for sure:
The U.S. government is set to buy 1.7 million courses of molnupiravir at $700 each, Reuters reported on Friday.
On Friday there was an options sweep of over 2.5 million in calls @ 82.50 for 12/17. As soon as I saw that I bought some. Hoping to make a fat profit of course.
Meanwhile I’ll stick with the horse paste - doesn’t taste bad...neigh neigh stomp stomp. :-)
And Pfizermectin.
It’s all ivermectin reworked.
I’d bet everything I own.
More expensive, and less effective too!
“the company’s pill molnupiravir could halve the chances of dying or being hospitalized for those most at risk of contracting severe COVID-19.”
“And Pfizermectin.
It’s all ivermectin reworked.
I’d bet everything I own.”
You forgot Modernmectin, which will also be out soon. I guess they’ve milked the ‘vaccines’ as much as they could and are now ready to put an end to the virus, as Uttar Pradesh has already done.
It will be years before the FDA swamp allows such a treatment to be approved.
Interesting coincidence, isn’t it, that by the end of the year, the PCR test will no longer be used to diagnose COVID.
Just in time for their miracle pill cure to come in and save the day, and voila‘, the “pandemic” is over.
Just waiting to see if it happens.
And of course, it’s just after the holidays so they will be trying to shut those down and rob us of that as well. And to top it off, they are manufacturing supply chain issues so even being able to get Christmas presents will be problematic.
All happening in the same time frame.
What a coincidence…….
If they weren’t similar in function, then they both would not work against COVID and Ivermectin has been demonstrated to do that many times over.
Add to that the infection rate coming down at a good clip.
It does almost seem that they’re trying to get moving on their Fascism before their opportunity is overcome by events.
They function completely different. Molnupiravir works through “lethal mutagenensis”. It introduces catastrophic errors during viral reproduction that render the virus copies inert. There are several theories on how ivermectin works vs SARS-CoV 2, but none of them are proven yet.
There are always “more ways than one to skin a cat”. Lethal mutagenensis is a strategy used in some other anti-viral and anti-cancer therapeutics, and has been around for a while. But there are many other strategies.
Karl Dinninger wrote a post about molnupiravir.
Merck’s New Drug - A Wonder Or Incipient Slaughter?
https://market-ticker.org/akcs-www?post=243781
Denninger
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.